Matches in Wikidata for { <http://www.wikidata.org/entity/Q74278682> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q74278682 description "clinical trial" @default.
- Q74278682 description "ensayu clínicu" @default.
- Q74278682 description "klinisch onderzoek" @default.
- Q74278682 description "клінічне випробування" @default.
- Q74278682 name "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 name "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 type Item @default.
- Q74278682 label "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 label "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 prefLabel "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 prefLabel "Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer" @default.
- Q74278682 P1132 Q74278682-E68A6902-483A-4EEF-BE6E-6983B7CD8DA1 @default.
- Q74278682 P1476 Q74278682-F339357D-2305-4995-BA46-B106315D6470 @default.
- Q74278682 P17 Q74278682-19FBD2A4-3857-4B89-8FD9-3E3D1AE8EAC7 @default.
- Q74278682 P1813 Q74278682-9AD27685-48CE-40BA-90A4-1B2D2362DF99 @default.
- Q74278682 P2899 Q74278682-585248DD-E6C0-4A09-9948-D7DED57AC527 @default.
- Q74278682 P3098 Q74278682-69F9ED6D-C658-4C16-9EDF-CF72D59BB350 @default.
- Q74278682 P31 Q74278682-971BD270-87EA-4AE7-A42C-BE8823A9C269 @default.
- Q74278682 P580 Q74278682-A93AB4DD-F1FF-415F-BB71-EB68524F7718 @default.
- Q74278682 P582 Q74278682-2ACED6DB-9AC2-48CF-B74B-683A3674D72C @default.
- Q74278682 P6099 Q74278682-C0EADC39-DA6D-4DBB-8F00-2EA545DA21FB @default.
- Q74278682 P8363 Q74278682-F0EF5170-F1D9-45CA-8222-384CFCEE6F70 @default.
- Q74278682 P1132 "+112" @default.
- Q74278682 P1476 "A Phase II Non-randomized, Single Group Assignment, Open-label, Multicenter Study of Efficacy and Safety of lORlatinib (PF-06463922) Monotherapy After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung cancEr" @default.
- Q74278682 P17 Q142 @default.
- Q74278682 P1813 "ORAKLE" @default.
- Q74278682 P2899 "+18" @default.
- Q74278682 P3098 "NCT04111705" @default.
- Q74278682 P31 Q30612 @default.
- Q74278682 P580 "2019-10-01T00:00:00Z" @default.
- Q74278682 P582 "2021-12-01T00:00:00Z" @default.
- Q74278682 P6099 Q42824440 @default.
- Q74278682 P8363 Q78089383 @default.